Simply because AIs dramatically lower the estrogen level in Females soon after menopause, they also can result in bone thinning, often bringing about osteoporosis as well as fractures. Progression developing six or maybe more months soon after initiating the primary endocrine therapy for metastatic condition (either fulvestrant or aromatase inhibitor https://camillaf196vze9.blog-a-story.com/profile